logo
welcome
CNBC

CNBC

FTC sues drug middlemen for allegedly inflating insulin prices

CNBC
Summary
Nutrition label

74% Informative

Federal Trade Commission sues U.S. health companies that negotiate insulin prices.

The FTC argues the drug middlemen boost profits while "artificially" inflating costs for patients.

The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx , CVS Health's Caremark and Cigna 's Express Scripts .

All are owned by or connected to health insurers and collectively administer about 80% of the nation's prescriptions.

VR Score

83

Informative language

88

Neutral language

31

Article tone

formal

Language

English

Language complexity

63

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links